{"id":"https://openalex.org/W2990902931","doi":"https://doi.org/10.3389/fphar.2019.01533","title":"Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers","display_name":"Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers","publication_year":2020,"publication_date":"2020-01-09","ids":{"openalex":"https://openalex.org/W2990902931","doi":"https://doi.org/10.3389/fphar.2019.01533","mag":"2990902931","pmid":"https://pubmed.ncbi.nlm.nih.gov/31998131","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6965315"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2019.01533","doi":"https://doi.org/10.3389/fphar.2019.01533","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.01533","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.01533/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.01533/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078533220","display_name":"Gaozhi Chen","orcid":"https://orcid.org/0009-0005-7604-8128","observed_orcids":["https://orcid.org/0009-0005-7604-8128"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Gaozhi Chen","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]},{"raw_affiliation_string":"Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106267626","display_name":"Yuyan Bao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuyan Bao","raw_affiliation_strings":["Department of Pharmacy, Sanmen People's Hospital of Zhejiang, Sanmen, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sanmen People's Hospital of Zhejiang, Sanmen, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007980016","display_name":"Qiaoyou Weng","orcid":"https://orcid.org/0000-0003-0023-4598","observed_orcids":["https://orcid.org/0000-0003-0023-4598"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiaoyou Weng","raw_affiliation_strings":["Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079291929","display_name":"Yingxin Zhao","orcid":"https://orcid.org/0000-0002-8872-5860","observed_orcids":["https://orcid.org/0000-0002-8872-5860"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingxin Zhao","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010476050","display_name":"Xiaoyao Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoyao Lu","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101575254","display_name":"Lili Fu","orcid":"https://orcid.org/0009-0009-0062-7931","observed_orcids":["https://orcid.org/0009-0009-0062-7931"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lili Fu","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009036115","display_name":"Lingfeng Chen","orcid":"https://orcid.org/0000-0003-0089-6559","observed_orcids":["https://orcid.org/0000-0003-0089-6559","https://orcid.org/0009-0006-7896-6165"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lingfeng Chen","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100636188","display_name":"Zhiguo Liu","orcid":"https://orcid.org/0000-0001-8986-4427","observed_orcids":["https://orcid.org/0000-0001-8986-4427"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhiguo Liu","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100332125","display_name":"Xiaomin Zhang","orcid":"https://orcid.org/0000-0003-4898-4152","observed_orcids":["https://orcid.org/0000-0003-4898-4152","https://orcid.org/0009-0001-0989-2063","https://orcid.org/0009-0004-0172-6433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaomin Zhang","raw_affiliation_strings":["Department of Pharmacy, Sanmen People's Hospital of Zhejiang, Sanmen, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sanmen People's Hospital of Zhejiang, Sanmen, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074286511","display_name":"Guang Liang","orcid":"https://orcid.org/0000-0002-8278-849X","observed_orcids":["https://orcid.org/0000-0002-8278-849X","https://orcid.org/0009-0005-1603-3223"]},"institutions":[{"id":"https://openalex.org/I27781120","display_name":"Wenzhou Medical University","ror":"https://ror.org/00rd5t069","country_code":"CN","type":"education","lineage":["https://openalex.org/I27781120"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Guang Liang","raw_affiliation_strings":["Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China","institution_ids":["https://openalex.org/I27781120"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074286511"],"corresponding_institution_ids":["https://openalex.org/I27781120"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.9681,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.88205937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"1533","last_page":"1533"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-tki-resistance","display_name":"EGFR tyrosine kinase inhibitor resistance","score":0.7310000061988831},{"id":"https://openalex.org/keywords/fgfr1","display_name":"FGFR1","score":0.7749999761581421},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/afatinib-resistance","display_name":"afatinib resistance","score":0.7730000019073486},{"id":"https://openalex.org/keywords/h1975-cells","display_name":"H1975 cells","score":0.8429999947547913},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/xenograft-tumor-growth-inhibition","display_name":"xenograft tumor growth inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.9301464557647705},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.771941065788269},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6237370371818542},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5849494934082031},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5285509824752808},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.51002436876297},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5084161162376404},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4869476556777954},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.43992993235588074},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.41967442631721497},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.4177703559398651},{"id":"https://openalex.org/C49418065","wikidata":"https://www.wikidata.org/wiki/Q14914258","display_name":"Fibroblast growth factor receptor 1","level":4,"score":0.4143143892288208},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.41226693987846375},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.36315977573394775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31643569469451904},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30105775594711304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2816507816314697},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24895921349525452},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.12813487648963928},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.11827287077903748},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08767271041870117},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2019.01533","doi":"https://doi.org/10.3389/fphar.2019.01533","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.01533","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.01533/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6965315","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6965315","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:31998131","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31998131","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:93625ff956364949ba16987d740fd076","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/93625ff956364949ba16987d740fd076","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 10 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2019.01533","doi":"https://doi.org/10.3389/fphar.2019.01533","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.01533","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.01533/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1358754759","display_name":null,"funder_award_id":"2017YFA0506000","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G4624551082","display_name":null,"funder_award_id":"2018KY183","funder_id":"https://openalex.org/F4320338464","funder_display_name":"Natural Science Foundation of Zhejiang Province"},{"id":"https://openalex.org/G4683723983","display_name":null,"funder_award_id":"81773579","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G4962902381","display_name":null,"funder_award_id":"LY17B020008","funder_id":"https://openalex.org/F4320338464","funder_display_name":"Natural Science Foundation of Zhejiang Province"},{"id":"https://openalex.org/G743146183","display_name":null,"funder_award_id":"2017YFA0506000","funder_id":"https://openalex.org/F4320338464","funder_display_name":"Natural Science Foundation of Zhejiang Province"},{"id":"https://openalex.org/G7438910195","display_name":"FGFR1\u819c\u5916\u77ed\u80bd\u6291\u5236\u5242G67\u7684\u6297\u80ba\u764c\u6d3b\u6027\u548c\u673a\u5236\u7684\u7814\u7a76","funder_award_id":"LYY19H310004","funder_id":"https://openalex.org/F4320338464","funder_display_name":"Natural Science Foundation of Zhejiang Province"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320338464","display_name":"Natural Science Foundation of Zhejiang Province","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990902931.pdf","grobid_xml":"https://content.openalex.org/works/W2990902931.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1908940658","https://openalex.org/W1967394241","https://openalex.org/W1983774108","https://openalex.org/W1993382872","https://openalex.org/W2007685062","https://openalex.org/W2021014232","https://openalex.org/W2021340312","https://openalex.org/W2042278676","https://openalex.org/W2043696829","https://openalex.org/W2063874384","https://openalex.org/W2065734290","https://openalex.org/W2088113192","https://openalex.org/W2090029719","https://openalex.org/W2093613683","https://openalex.org/W2093826193","https://openalex.org/W2096861064","https://openalex.org/W2108947370","https://openalex.org/W2109678955","https://openalex.org/W2110861505","https://openalex.org/W2124511021","https://openalex.org/W2131088620","https://openalex.org/W2133963438","https://openalex.org/W2135125731","https://openalex.org/W2135507887","https://openalex.org/W2138604360","https://openalex.org/W2139236349","https://openalex.org/W2154349915","https://openalex.org/W2161608625","https://openalex.org/W2161821474","https://openalex.org/W2402506318","https://openalex.org/W2533710847","https://openalex.org/W2560717039","https://openalex.org/W2756275807","https://openalex.org/W2770240948","https://openalex.org/W2885289995","https://openalex.org/W2909222524","https://openalex.org/W2945712323","https://openalex.org/W2948035094","https://openalex.org/W2964016456","https://openalex.org/W2972693655"],"related_works":["https://openalex.org/W1609712290","https://openalex.org/W2469307120","https://openalex.org/W2537921923","https://openalex.org/W2151175247","https://openalex.org/W6981565862","https://openalex.org/W2741698088","https://openalex.org/W2161472240","https://openalex.org/W2408603676","https://openalex.org/W4391598431","https://openalex.org/W2969551456"],"abstract_inverted_index":{"In":[0],"the":[1,20,29,32,46,59,84,107,120,129,149,187],"past":[2],"decades,":[3],"epidermal":[4],"growth":[5],"factor":[6],"receptor-tyrosine":[7],"kinase":[8,93],"inhibitors":[9],"(EGFR-TKIs)":[10],"had":[11],"been":[12],"proved":[13],"as":[14,182],"an":[15],"effective":[16],"treatment":[17,101],"strategy":[18],"for":[19,31,39,63,118,186],"patients":[21,191],"with":[22,96,171],"EGFR-mutated":[23],"non-small-cell":[24],"lung":[25],"cancer":[26],"(NSCLC).":[27],"However,":[28],"tolerance":[30],"EGFR-TKI":[33,64,85,122,185],"always":[34],"occurred":[35],"after":[36],"continuous":[37],"administration":[38],"a":[40,69,163,183,193],"period":[41],"of":[42,48,52,58,73,91,109,152,189],"time":[43],"and":[44,75,80,98,111,128,139],"limiting":[45],"application":[47],"these":[49],"drugs.":[50],"Activation":[51],"FGFR1":[53,99,112],"signaling":[54],"pathway":[55],"was":[56,78,116,166],"one":[57],"important":[60],"escape":[61],"mechanism":[62],"resistant":[65],"in":[66,124,132,158,174],"NSCLC.":[67],"Here,":[68],"novel":[70],"dual":[71],"inhibitor":[72,100],"EGFRL858R/T790M":[74,97,110],"FGFR1,":[76],"compound15c,":[77],"found":[79],"can":[81],"efficiently":[82],"overcame":[83],"resistance":[86,123,131,194],"via":[87],"its":[88],"simultaneous":[89],"inhibition":[90,108],"their":[92],"activities.":[94],"Comparison":[95],"alone":[102],"or":[103],"combined":[104],"revealed":[105],"that":[106,145],"activity":[113,141],"by":[114,162,168],"15c":[115,146,169,179],"responsible":[117],"surmounting":[119],"intrinsic":[121],"EGFRL858R/T790M-mutated":[125],"H1975":[126,153,164],"cells":[127,135,165],"acquired":[130],"Afatinib-tolerant":[133],"PC9":[134],"(AFA-PC9).":[136],"Flow":[137],"Cytometry":[138],"Caspase3":[140],"analysis":[142],"assay":[143],"showed":[144],"induced":[147,161],"significant":[148],"early":[150],"apoptosis":[151],"cells.":[154],"Xenograft":[155],"tumor":[156],"formation":[157],"BALB/c":[159],"mice":[160],"suppressed":[167],"treatment,":[170],"no":[172],"changes":[173],"animal":[175],"body":[176],"weight.":[177],"Generally,":[178],"may":[180],"act":[181],"new-generation":[184],"therapy":[188],"NSCLC":[190],"suffering":[192],"to":[195],"current":[196],"TKI.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-12-05T00:00:00"}